Project Grant H79TI088524
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded the University of Connecticut Health Center $300,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to develop a comprehensive substance use disorder education and clinical readiness program for health professional students. The University of Connecticut Comprehensive SUD Education and Clinical...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment awarded the American Society of Addiction Medicine Inc. $2,999,542 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to implement the Providers Clinical Support System – Substance Use Disorder Treatment (PCSS-SUD Treatment). PCSS-SUD Treatment is a national training and technical assistance program...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded La Maestra Family Clinic, Inc., $545,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to expand evidence-based substance use disorder and co-occurring disorder treatment services for youth and young adults ages 12–25 in San Diego County. La Maestra, a federally qualified health center and San Diego-based nonprofit, will...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA Center for Substance Abuse Treatment) awarded Children's Hospital Los Angeles $545,000 under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) on September 30, 2026. The award funds comprehensive evidence-based substance use disorder (SUD) and co-occurring disorder (COD) treatment services for youth ages 12–17 and young adults...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Mississippi State University $375,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to expand access to evidence-based substance use disorder and dual diagnosis treatment for college-aged youth across Mississippi. The project will provide pro-bono substance use disorder or dual diagnosis...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded $400,000 to the San Francisco County Superior Court on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to expand the San Francisco Adult Drug Court. The award funds the addition of two full-time positions to extend court capacity and services to two underserved populations: justice-involved adults...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded the Public Health Institute $600,000 on September 30, 2026, under the Center for Substance Abuse Prevention Projects of Regional and National Significance program (CFDA 93.492) to implement the Youth Prevention Partnership Project for young adults with substance use risk in Alameda and San Francisco Counties, California. The project delivers substance use prevention and early...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Marshall University Research Corporation $299,519 under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) on September 30, 2026. The award funds training of graduate-level health professional students to deliver substance use disorder services in rural and medically underserved areas of West Virginia. Marshall University's...
- The Substance Abuse and Mental Health Services Administration awarded the Regents of the University of California, San Francisco $1.869 million on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532) to establish the UCSF Center of Excellence for Eating Disorders. UCSF will deliver gold-standard training and technical assistance in eating disorder screening, diagnosis, and evidence-based treatment to healthcare,...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) awarded the California Department of Health Care Services $716.886 million on October 1, 2025, under the Block Grants for Prevention and Treatment of Substance Abuse program (CFDA 93.959). The award, which carries an ultimate completion date of September 30, 2027, provides financial assistance to California to support projects for prevention, treatment, and rehabilitation activities...
The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded the University of California, San Diego three hundred thousand dollars on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to develop and deliver comprehensive graduate education on substance use disorders. The award funds the UC San Diego Comprehensive Graduate Education for Substance Use Disorders Initiative, which will train approximately 414 health professional learners annually, including physician assistant students, medical students, psychiatry residents, nursing and psychiatric mental health nurse practitioner students, and clinical psychology doctoral students. The initiative will integrate evidence-based SUD curricula, interdisciplinary training, mentorship, and community-based clinical placements across San Diego and Imperial Counties. Deliverables include curriculum mapping, integration of required PCSS-U content, experiential and simulation training, faculty development, establishment of clinical partnerships, and development of a sustainability plan to prepare learners to prevent, identify, assess, treat, and support recovery for individuals with substance use disorders. Place of performance is La Jolla, California. The period of performance runs from September 30, 2026, through September 29, 2029.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $300.0k | 8/18/26 |